| Date Posted |
Subject |
| Oct. 10, 2011 |
Managing bloody contaminated umbilical cord specimen collection tubes |
| Sept. 18, 2011 |
Immunohematological tests that assess risk for significant ABO Hemolytic Disease of the Fetus/Newborn (HDF/N) ADDENDA Sept. 30 & Nov. 10 |
| July 25, 2011 |
Who should dispense Rh Immune Globulin (RhIg): blood bank or pharmacy? ADDENDA Aug. 17, 2011 |
| Nov. 14, 2010 |
Performing an immediate spin or electronic crossmatch for women who have detectable passively acquired anti-D from antenatal RhIg administration ADDENDA Dec. 16 |
| Sept. 29, 2010 |
Is a second sample required for Rh Immune Globulin? |
| June 20, 2010 |
How do institutions report the findings of antibody identification panels for patients who have received Rh Immune Globulin? ADDENDA Sept. 1 |
| June 9, 2010 |
Antibody titration testing for pregnant women with very weak red cell alloantibodies |
| Feb. 3, 2010 |
Pregnancy, HTLA antibodies and risk of hemolytic disease of the fetus/newborn |
| Jan. 24, 2010 |
Inconsistent Rh typing results |
| Dec. 29, 2009 |
Availability of the Kleihauer-Betke test for work up of fetal bleeding following maternal trauma ADDENDA Dec. 30, 2009; Jan. 3 & 20,Feb. 15, 2010 |
| Dec. 20, 2009 |
Reporting Rh status of women in California ADDENDA Dec. 27 & 29 |
| Nov. 27, 2009 |
Appropriate reference range when reporting results of the Kleihauer-Betke test |
| July 26, 2009 |
Antibody titer testing on pregnant women when the patient has an antibody known to possibly cause hemolytic disease of the newborn/fetus (HDN/F) ADDENDA Aug. 3 & 24 |
| Mar. 24, 2009 |
Management of dispensing Rh Immune Globulin (RhIg) through Pharmacy ADDENDA May 15 |
| Jan. 28, 2009 |
Management of Rh-negative girls or woman of childbearing age transfused with one or more Rh-positive RBC units |
| Oct. 25, 2008 |
Testing for fetal maternal hemorrhage using a post-partum blood sample collected 1-2 hours versus 12-24 hours after delivery ADDENDA Nov. 2, 3, 11 & 23; Dec. 15 |
| July 16, 2008 |
Using a 'calculator' to determine RhIG dosage |
| Jan. 12, 2008 |
Testing
for ABO using umbilical cord blood samples and avoidance of false
positive test results due to Wharton's Jelly |
| Dec. 13, 2007 |
When
is additional RhIG required? ADDENDA Jan.
1, 9 & 25, 2008 |
| Nov. 27, 2007 |
Induction of an inhibitor
antibody to factor XI in a patient with severe inherited factor XI
deficiency |
| Oct. 5, 2007 |
Managing
a patient with whose post partum blood specimen
tests positive in a rosette screening test for
fetal-maternal hemorrhage, but tests negative in
a Kleihauer-Betke (KB) or a flow cytometry test
for the presence of Hgb F containing red cells ADDENDA Oct. 15 |
| July 31, 2007 |
Determining
the correct dosage of RHIG for immunoprophylaxis
of feto-maternal hemorrhage (FMH) ADDENDA Aug.
1, 2, 3, 5 & 10 |
| June 22, 2007 |
Managing
neonates whose mothers have identified red cell
antibodies ADDENDA July 9 & 16 |
| May 2, 2007 |
Indications to perform a titer when anti-D is detected in a patient who has received Rh Immune Globulin ADDENDA May 4, 8 & 13 |
| Mar. 30, 2007 |
Are institutions following the recommendation that women, regardless of inital Rh type, be tested at least twice for RhD during their first pregnancy? |
| Jan. 13, 2007 |
When considering Rh immunoprophylaxis for an Rh negative woman, if a test for D on her newborn baby is negative, what methods are used to rule out the possibility that the newborn has a "Weak D" phenotype? ADDENDA Feb. 13; Mar. 27, 2008 |
| June 16, 2006 |
A case of possible 'auto'anti-D during pregnancy? |
| May 3, 2006 |
Management of pregnancies that are complicated by non-D alloantibodies that have clinically-significant specificities ADDENDA May 4, 8 & 17; Aug. 15 |
| April 25, 2006 |
Is there evidence that girls and premenopausal women who need transfusion should receive donor RBC units that are phenotype tested and matched for CDE and K antigens, to reduce risk of alloimmunization and prevent future cases of hemolytic disease of the newborn? ADDENDA May 8 & 12 |
| Apr. 23, 2006 |
Practices regarding selection of CMV seronegative and/or leukocyte reduced blood products for transfusion of pregnant patients ADDENDA Apr. 24 & 26 |
| Apr. 21, 2006 |
Should pregnant women who need transfusion receive irradiated blood products to prevent Graft versus Host Disease? ADDENDA Apr. 23, 25 & 26 |
| Feb. 7, 2006 |
How much pretransfusion testing should be done for a patient with anti-D, acquired by having received an injection of RhIG? ADDENDA Feb. 27 & Mar. 12 |
| Jan. 30, 2006 |
Should a hospital dispense Rh Immune Globulin (RhIG) for a patient, in the absence of a current Rh determination on the patient? ADDENDA Feb. 7 & 15 |
| Dec. 21, 2005 |
Limiting RHIG prophylaxis based on prenatal determination of fetal Rh status ADDENDA Jan. 2, 2006 |
| Sept. 14, 2005 |
Availability of and experience with Fetal RhD genotype testing ADDENDA Sept. 21 |
| June 14, 2005 |
Use of platelets for intrauterine transfusions ADDENDA July 7 |
| April 7, 2005 |
Should CMV safe blood components be provided for transfusion to post-partum women? |
| Mar. 10, 2005 |
Policies for testing donors, patients and pregnant women for the DVI Rh variant (a form of weak D) ADDENDA Mar. 16 |
| Feb. 21, 2005 |
Strategies for selecting best Rh phenotype for intrauterine red cell transfusion for reasons other than hemolytic disease of the newborn ADDENDA Feb. 28 |
| Feb. 10, 2005 |
Strategies for antigen typing an alleged "father" of a fetus whose mother has developed alloantibodies capable of causing hemolytic disease of the newborn ADDENDA Feb. 14 |
| Jan. 11, 2005 |
Methods for quantitating fetal red cells in maternal blood ADDENDA Jan. 12, 13, 18 & 30 |
| Nov. 26, 2004 |
Must a current blood sample always be tested for Rho(D) type prior to administration of Rh immune globulin? ADDENDA Nov. 30, Dec. 5, 18 & 21 |
| Oct. 30, 2004 |
Informed consent for administration of Rh Immune Globulin |
| Sept. 21, 2004 |
TRALI after IV anti-D (RhIg) ADDENDA Sept. 29 |
| Sept. 6, 2004 |
Management of a pregnant woman who may have native anti-D, but has also received an antepartum dose of RhIG |
| July 21, 2004 |
Use of Rh immune globulin (RhIg) in Rh-negative female children receiving platelets from Rh-positive donors ADDENDA July 26 |
| June 21, 2004 |
Role of the husband's Rh (D) status in policies for administering RhIg to pregnant Rh-negative women ADDENDA June 30, Aug. 18, Sept 17 & 29 |
| June 17, 2004 |
Does a history of transient passively acquired anti-D from receipt of RhIG disqualify a patient for an electronic crossmatch? ADDENDA June 23 |
| Apr. 8, 2004 |
Justification for requesting routine antibody identification and titer on women who have received RhIG during pregnancy ADDENDA Apr. 14 |
| Jan. 29, 2004 |
Impact of new policies to eliminate tests for weak D on the decision to administer RhIG in pregnant women who were designated weak D on previous Rh testing protocols ADDENDA Jan. 30 & Feb. 5 |
| Nov. 7, 2003 |
Why do transfusion services in the US not consider Kell antigen when crossmatching red cells intended for women of childbearing age? ADDENDA Nov. 10 |
| Oct 29, 2003 |
Practices regarding RhIG administration in response to 22nd edition of AABB Standards ADDENDA Nov. 3 |
| Aug 30, 2003 |
A case report of an allergic type reaction to the injection of RHIG ADDENDA Sept. 1, 2 & 4 |
| Aug 15, 2003 |
An unusual case report of massive feto-maternal hemorrhage in an Rh negative woman ADDENDA Aug. 18 |
| July 23, 2003 |
Should the hospital pharmacy participate in the dispensing of Rh Immune Globulin (RhIg)? |
| May 27, 2003 |
Limitation to
new method for quantification of feto-maternal
haemorrhage (FMH) by flow cytometry with anti-fetal
haemoglobin ADDENDA Jan
29, 2005; July 9 & 11, 2007 |
| May 3, 2003 |
What do colleagues do in their practice regarding testing for fetomaternal bleeds and/or the use of micro versus full doses of RHIG? ADDENDA May 8; Oct. 7, 2005 |
| Jan. 17, 2003 |
Distinguishing
anti-G from anti-C+D in prenatal serologic studies ADDENDA Jan.
20 & 21; Mar. 16, 2009 |
| Jan. 7, 2003 |
In performing titration studies for NON-Rh antibodies in pregnant women, what is the practice regarding selection of reagent red cells that are heterozygous vs homozygous for the antigen in question? ADDENDA Jan. 9; Dec. 21, 2005 |
| Jan. 1, 2003 |
In selecting Rh positive reagent red cells for prenatal anti-D studies does the Rh phenotype affect the results of the titration? ADDENDA Jan. 2 & 6 |
| Nov. 8, 2002 |
A case report of the mysterious development of anti-D in pregnancy ADDENDA Nov. 12 & 13; Mar. 25 & 27, 2003 |
| Oct. 27, 2002 |
Should RBCs used for intrauterine transfusion be washed and/or adjusted to a high Hct? ADDENDA Oct. 28 & 30 |
| Oct. 22, 2002 |
Should a test for fetomaternal hemorrhage (FMH) be done before administering Rh Immune Globulin to Rh-negative women at risk of FMH in early pregnancy? ADDENDA Oct. 23; Oct. 7, 26 & 28, 2005 |
| Sept. 13, 2002 |
Is Rh Immunoglobulin (RhIG) necessary when platelets from Rh-incompatible donors are given to females of child-bearing potential? |
| Aug. 16, 2002 |
Should one offer Rh immunoprophylaxis for a woman who delivers a baby determined to be Dvi positive? ADDENDA Aug. 17 & 28 |
| Aug. 8, 2002 |
Improved Methods for Quantitating Fetal-Maternal Hemorrhage ADDENDA Aug. 9; Jan. 12, 2005 |
| June 14, 2002 |
Antibody titer studies in pregnant women at risk for bearing an infant with hemolytic disease of the newborn ADDENDA June 18 & 19; May 7, 10 & 16, 2008 |
| June 12, 2002 |
Recommendations for storage of RHIG (Rh Immune Globulin) ADDENDA June 13 & 14 |
| Sept. 28, 2001 |
Rh immune globulin (RHIG) administration after transfusion of Rh-pos platelets/plateletpheresis units to Rh-neg recipients ADDENDA Sept. 28 & 29 |
| Sept. 7, 2001 |
Performance of blood bank testing for obstetric patients at delivery ADDENDA Sept. 8 |
| Aug. 14, 2001 |
Routine cord blood serologic testing - Who needs it? ADDENDA Aug. 15 & 17; Dec. 1, 2001; July 5 & Aug. 7, 2003, 2003; Mar. 15, 2007 |
| May 1, 2001 |
Antibody detection testing practices for Rh negative pregnant women who have received Rh Immune Globulin |
| Feb. 28, 1999 |
Repeat testing for weak D in females of childbearing age? |
